List of Treatments for Bladder Cancer

Below is a listing of treatments and therapies for bladder cancer. Click on one to read more information or connect with others currently using it.

Adstiladrin (Nadofaragene Firadenovec-Vncg)

Overview
Adstiladrin is approved by the U.S. Food and Drug Administration (FDA) to treat adults with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC). This includes…

read more

Anktiva (Nogapendekin Alfa Inbakicept)

Overview
Anktiva is approved by the U.S. Food and Drug Administration (FDA) along with Bacillus Calmette-Guérin (BCG) to treat adults with a type of bladder cancer called BCG-unresponsive nonmuscle invasive bladder cancer…

read more

Balversa (Erdafitinib)

Overview
Balversa is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with locally advanced or metastatic urothelial carcinoma (a type of bladder cancer) with specific fibroblast growth…

read more

Bavencio (Avelumab)

Overview
Bavencio is approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of locally advanced or metastatic urothelial carcinoma (a type of bladder cancer) that has not progressed with…

read more

Imfinzi (Durvalumab)

Overview
Imfinzi is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with muscle-invasive bladder cancer (MIBC) in combination with chemotherapy prior to surgery (neoadjuvant), followed…

read more

Keytruda (Pembrolizumab)

Overview
Keytruda is approved by the U.S. Food and Drug Administration (FDA) to treat certain types of bladder cancer. It is prescribed to treat advanced or metastatic (spreading) urothelial cancer, the most common type…

read more